↓ Skip to main content

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension

Overview of attention for article published in Cochrane database of systematic reviews, November 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
29 tweeters
facebook
2 Facebook pages
wikipedia
1 Wikipedia page

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
66 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension
Published in
Cochrane database of systematic reviews, November 2018
DOI 10.1002/14651858.cd008170.pub3
Pubmed ID
Authors

Yu Jie Chen, Liang Jin Li, Wen Lu Tang, Jia Yang Song, Ru Qiu, Qian Li, Hao Xue, James M Wright

Twitter Demographics

The data shown below were collected from the profiles of 29 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 3%
Student > Postgraduate 1 2%
Unspecified 1 2%
Unknown 62 94%
Readers by discipline Count As %
Unspecified 2 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Medicine and Dentistry 1 2%
Unknown 62 94%

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2019.
All research outputs
#791,908
of 13,139,039 outputs
Outputs from Cochrane database of systematic reviews
#2,564
of 10,497 outputs
Outputs of similar age
#33,126
of 298,167 outputs
Outputs of similar age from Cochrane database of systematic reviews
#28
of 56 outputs
Altmetric has tracked 13,139,039 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,497 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.6. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 298,167 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.